Member Info for Hubstar

2M buy at near full ask 1.155p

Wakey wakey

This is why Kefi will multibag on just Tulu Kapi alone :-)

"These metrics position Tulu Kapi as a highly cash-generative project. Even with gold at US$2,500/oz, operating cash flow would be expected to exceed total project debt in the first full year of production, fuelling rapid deleveraging and value realisation for shareholders."

Kefi have confirmed today that Tulu Kapi is now de-risked and will provide sector leading profits over the initial seven years ( in relative terms ) also on the Vox interview Harry gave heavy hints the further TK type will be added to the asset base. One word NICE :-)

· Average EBITDA of approximately US$355 million to US$697 million per annum over the first three years of production, equating to approximately US$305 million to US$599 million per annum net to KEFI;

· All-in Sustaining Costs of US$1,114 to US$1,254 per ounce;

· The all-in-cost after all debt servicing is approximately US$1,366-1,506 per ounce; and

· A Net Present Value (NPV) ranging from $1.1 billion at the start of construction (with gold at $3000/oz) to $2.4 billion at the start of production (with gold at $5000/oz). These figures reflect a 5% NPV discount and apply to KEFI's expected 86% beneficial interest and are net of all capital servicing. Total net cashflow over seven years of US$1.8 billion to US$3.4 billion at gold prices of US$3,000 to US$5,000 per ounce.

These metrics position Tulu Kapi as a highly cash-generative project. Even with gold at US$2,500/oz, operating cash flow would be expected to exceed total project debt in the first full year of production, fuelling rapid deleveraging and value realisation for shareholders.

Target,i still say dont be suprised if they release news on Saudi and a new Asset perhaps, Saudi game has changed since January when state owned Ma'aden announced massive new discoveries,the big boys are lining up right now.

Target.......Kefi are seeking a move to a Main Market listing next year ( 2027 ) so that is why they are active right now getting everything sorted,we know TK alone is likely to provide a solid multibagger here but Kefi are also trying to build and add to the asset portfolio to create a genuine Midcap producer with an eye on large cap status in the future. Harry and Kefi are not stupid ( they know they are now seriously in business after many years of waiting ) and are in a strong position to build the company.

You say no progress no news ,i say quite the opposite,this is the period where the company is really being built because they have the means and opportunity to do it :-)

I am still curious why Jeff Rayner was with Harry in Ethiopia ( maybe still there ) and i also think the recent statement on Saudi is connected, have they found another TK type asset ?? Jeff,s record is second to none in the industry at finding great mining opportunities. When i join the dots i dont see Kefi wanting to be a bit part player in Saudi when they have one of the most lucrative Gold assets in the world going into production and likely to produce over $5Bn in revenue from just a small part of Tulu Kapi Licence area over ten years and likely has the same amount or more Gold underground .

If Kefi were offered say £100m to exit Saudi and invest into another majority owned and operated project elsewhere i think they would be chomping at the bit to do it.I believe the last time Saudi was valued it was at $138m but consider at the time Gold spot prices were around $2400,so with Gold now around $4500 the chances of a Saudi buyer being keen must have improved many times over.

Just also seen latest in Ethiopia, Prime minister is expected to win election by a landslide according to latest Polling and local reporting,those on here that keep stating there will be no news for many months are way off the mark in my opinion,Kefi are actively trying to put the company in its best possible position ahead of the move to a main market listing and that will likely mean the sale of Saudi and adding a new TK type asset quite soon.

Happy days

Sale of Saudi and New Licence award are two news items i am expecting shortly,if Kefi can bring in around $100m from the sale i will be very happy :-)

Harry has told us before that Kefi have a fantastic situation in Ethiopia and everything has slotted into place - SERENDIPITY !

Mr P.....a very interesting development i would say :-)

I think we are very close to some major Saudi news and also news of a new licence award in Ethiopia ,as i said before if Kefi can cash in say £100m from the Saudi assets and add another TK style asset it would fit nicely with our future projection into a midcap producer with ambitions of a large cap.

Happy days at Kefi will soon be here IMVHO

Czar, certainly an intrigue building here now,we know they already have approvals in New York which is said to be the toughest state in USA to get approvals and are now due FDA approval for whole of USA - so timing of this 13% will raise a few eyebrows to say least.

It looks like we could be moving rapidly now - someone just taken a 13% stake in the company in one hit :-)

FDA ???? news

Someone just taken 13% of Genincode - is this the starting gun ??

Large delayed buy ? could have been over 3m at full ask

Mr P, the size of the commercial market for Genincode is truly huge and the appeal of huge savings for health services around the world will attract a potential buyer for the company. Someone like ROCHE would fancy this in my opinion.

A dead cert for a future TO

Good luck Mr P :-) I BELIEVE we are about to enter a very exciting period that will be news rich

Mr PosiTive, there was always an expectation that the FDA approval decision would land around the start of Q2 ( now ) for me what make this exciting is that they already have full approvals in New York, and according to respected journalists that cover all things FDA in the USA they all seem to suggest that New York is one of the hardest states to get anything medical related approved,so the fact Genincode already have this bodes very well for the wider USA approvals.

The USA market alone is huge for Genincode and enough to multiply the current SP many times,but imagine the wider Global situation with heart related problems.There is some serious life changing upside here from current levels (placing level ). Tempted to have a cheeky double up tomorow :-)

MF2017, I honestly believe that Kefi now have a completely different outlook on the future,now being the proud owner and operator of a soon to be producing multi-billion Gold asset in Ethiopia i think their focus is now purely on majority owned / operated assets that they can fully control.As such i am confident that Saudi will be viewed now as an investment to cash-in and invest in a majority owned new project. The reference of the $138m valuation is of course a lowball real world estimate that could easily be achieved ( i suggest £100m GBP could be a figure to watch for ) .With the current Geo-political situation i think a sale will just be too tempting for Kefi and Harry and will be viewed as a smart move in Kefi overall plan for the future.

There is currently some big money moving into Saudi and an appetite to invest,so with Jibal Outman near production ready and the much large Hawiah not far behind i can see an opportunity for Kefi to cash in now. Interesting times ahead in my opinion .

GENinCode plc represents a classic high-upside biotechealth tech opportunity that is currently transitions from the "regulatory risk" phase to the "commercial scaling" phase.Massive Total Addressable Market (TAM): Millions of preventive cardiac screenings are performed annually in the US and Europe. Capturing even a fraction of this market offers exponential revenue growth.High-Margin SaaS/Kit Model: As a diagnostic test provider utilizing proprietary bioinformatics software, the company benefits from scalable, high-margin revenue streams once integrated into institutional laboratories.

GENinCode plc represents a high-upside medtech opportunity as it transitions from regulatory approval to global commercial scaling.

Massive Market Potential: Cardiovascular disease is the world's leading killer. GENinCode’s advanced genetic tests address a multi-billion-dollar un-met preventive health market.

De-Risked for Growth: Recent New York State approval validates the technology under the strictest regulatory standards. This paves a clear path for nationwide US FDA clearance.

Scalable Business Model: The combination of proprietary bioinformatics software and test kits delivers highly scalable, high-margin revenue streams.

Discounted Entry Point: The current valuation reflects historic regulatory waiting periods. Early investors capture maximum upside before the full-scale US commercial launch drives revenue.

I am expecting some news here shortly,potential sale of Saudi assets either part or full and a new licence award in Ethiopia, why was Jeff Rayner in Addis with Harry ?? joint the dots .